Ovid Therapeutics Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ovid Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Ovid Therapeutics Inc. Depreciation for the quarter ending September 30, 2024 was $105K, a 0.96% increase year-over-year.
  • Ovid Therapeutics Inc. Depreciation for the twelve months ending September 30, 2024 was $412K, a 8.27% decline year-over-year.
  • Ovid Therapeutics Inc. annual Depreciation for 2023 was $420K, a 31.4% increase from 2022.
  • Ovid Therapeutics Inc. annual Depreciation for 2022 was $319K, a 315% increase from 2021.
  • Ovid Therapeutics Inc. annual Depreciation for 2021 was $76.9K, a 28.1% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $420K +$100K +31.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $319K +$242K +315% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $76.9K +$16.9K +28.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 $60K +$21K +53.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $39K +$4K +11.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $35K +$8.08K +30% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $26.9K +$10.6K +65.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $16.3K +$12.4K +317% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $3.9K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.